PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)
Status:
Completed
Trial end date:
2011-12-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish the safety and efficacy of multiple administrations
of PROCHYMAL® in subjects recently diagnosed with type 1 diabetes mellitus.